These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2660951)

  • 1. Loss of D1 and D2 dopamine receptors and muscarinic cholinergic receptors in rat brain following in vitro polytron homogenization.
    Norman AB; Borchers MT; Wachendorf TJ; Price AL; Sanberg PR
    Brain Res Bull; 1989 Apr; 22(4):633-6. PubMed ID: 2660951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
    Koda H; Hashimoto T; Kuriyama K
    Jpn J Pharmacol; 1989 Feb; 49(2):215-23. PubMed ID: 2659861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute and subacute administration of bicuculline on dopamine and muscarinic receptors in rat brain.
    Lim DK; Ito Y; Hoskins B; Ho IK
    Brain Res Bull; 1988 Jul; 21(1):21-4. PubMed ID: 3064880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]spiperone and [3H]quinuclidinyl benzilate binding in striatal membranes from rats chronically treated with manganese chloride throughout development and for over two years.
    Leung TK; Lai JC; Lim L
    Gen Pharmacol; 1986; 17(1):121-3. PubMed ID: 3949146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.
    Dawson VL; Dawson TM; Wamsley JK
    Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic and cholinergic muscarinic receptor effects of L-alphacetylmethadol (LAAM) and its metabolites.
    Langley AE; Smith SG; Zeid RL
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):350-5. PubMed ID: 6463046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 and muscarinic receptor binding characteristics in rat brain after withdrawal of subchronic fluphenazine and sulpiride treatment.
    Hietala J; Syvälahti E; Röyttä M
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):247-58. PubMed ID: 2526352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
    Syvälahti EK; Hietala J; Röyttä M; Grönroos J
    Pharmacol Toxicol; 1988 Apr; 62(4):210-2. PubMed ID: 3387375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic and dopaminergic receptors in the aging human brain.
    Rinne JO
    Brain Res; 1987 Feb; 404(1-2):162-8. PubMed ID: 3567563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary cell cultures contain muscarinic receptors.
    Taylor RL; Burt DR
    Eur J Pharmacol; 1980 Jul; 65(2-3):305-8. PubMed ID: 6249627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic cholinergic receptors in developing rat lung.
    Whitsett JA; Hollinger B
    Pediatr Res; 1984 Nov; 18(11):1136-40. PubMed ID: 6514439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.
    Florijn WJ; De Boer T; Tonnaer JA; Van Nispen JW; Versteeg DH
    Eur J Pharmacol; 1991 May; 207(1):43-50. PubMed ID: 1680721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in muscarinic cholinergic, PCP, GABAA, D1, and 5-HT2A receptor binding, but not in benzodiazepine receptor binding in the brains of aged rats.
    Nabeshima T; Yamada K; Hayashi T; Hasegawa T; Ishihara S; Kameyama T; Morimasa T; Kaneyuki T; Shohmori T
    Life Sci; 1994; 55(20):1585-93. PubMed ID: 7968230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
    Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
    Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.